L Virgolini and V Marzocchi (2003) “Anti-CD20 monoclonal antibody (rituximab) in the treatment of autoimmune diseases. Successful result in refractory Pemphigus vulgaris: report of a case”, Haematologica. Pavia, Italy, 88(7), pp. ELT24-ELT24. doi: 10.3324/%x.